Sars-Cov-2 Mrna-1273 (6M-5Y) Vaccine Dosage
Applies to the following strengths: preservative-free
Usual Pediatric Dose for:
Additional dosage information:
Usual Pediatric Dose for COVID-19
For investigational use only
6 months through 5 years:
- Primary series: 0.25 mL IM for 2 doses, administered 1 month apart
Comments:
- The US FDA issued an Emergency Use Authorization (EUA) to allow the emergency use of this unapproved product for active immunization to prevent coronavirus disease 2019 (COVID-19). This product is not approved by the US FDA for this use.
- There are no data available regarding interchangeability of COVID-19 vaccine products; the same vaccine product should be used for both doses.
- For additional information: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Use: Active immunization against COVID-19 due to SARS-CoV-2 (SARS-CoV-2)
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS: None
Safety and efficacy have not been established in patients younger than 6 months.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Administer IM.
- Gently swirl the vial between doses; do not shake.
Storage requirements:
- Store frozen between -50C to -15C (-58F to 5F); store in original package to protect from light.
- Thaw each vial before use; once thawed, do not return vial to freezer.
- Thawed vials may be handled in room light conditions.
- Vials may be stored between 8C and 25C (46F to 77F) for a total of 24 hours.
- Thawing vials: Consult the Fact Sheet for Health Care Providers.
- May store vials in refrigerator between 2C to 8C (36F to 46F) for up to 30 days prior to first use.
- In use vial (needle-punctured): Store between 2C to 25C (36F to 77F); discard vial 12 hours after first puncture.
- Do not refreeze.
Reconstitution/preparation techniques:
- Do not dilute.
- Consult the Fact Sheet for Health Care Providers.
General:
- Each 0.25 mL dose contains 25 mcg of a nucleoside-modified messenger RNA encoding the viral spike (S) glycoprotein of SARS-CoV-2.
Patient advice:
- Read the Fact Sheet for Recipients and Caregivers.
More about sars-cov-2 mrna-1273 (6m-5y) vaccine
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
